Cytotoxicities and quantitative structure activity relationships of B13 sulfonamides in HT-29 and A549 cells

Korean Journal of Physiology and Pharmacology

Volumn 15, Issue 6, 2011, Pages 423-429

  Lee, Seul Ki Chan ^a   Park, Sang Min ^a   Im, Chaeuk ^a  

^a Chung Ang University   (South Korea)

Author keywords

B13; Ceramide; Cytotoxicity; QSAR; Sulfonamides

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMIDE; ANTINEOPLASTIC AGENT; B13 SULFONAMIDE DERIVATIVE; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL STRAIN HT29; COLON CANCER; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG CANCER; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOCHEMISTRY;

EID: 84862939165     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2011.15.6.423     Document Type: Article

References (36)

1. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274:1855-1859. (Pubitemid 26424756)
2. Haimovitz-Friedman A, Kolesnick RN, Fuks Z. Ceramide signaling in apoptosis. Br Med Bull. 1997;53:539-553. (Pubitemid 27397309)
3. Fillet M, Bentires-Alj M, Deregowski V, Greimers R, Gielen J, Piette J, Bours V, Merville MP. Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity. Biochem Pharmacol. 2003;65:1633-1642. (Pubitemid 36577276)
4. Kim HJ, Song JY, Park HJ, Park HK, Yun DH, Chung JH. Naringin Protects against Rotenone-induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells. Korean J Physiol Pharmacol. 2009;13:281-285.
5. Hannun YA, Obeid LM. The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J Biol Chem. 2002;277:25847-25850. (Pubitemid 34967060)
6. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. Molecular machinery for non-vesicular trafficking of ceramide. Nature. 2003;426:803-809. (Pubitemid 38056858)
7. Lee DW, Park SY, Ryu JS, Kim SH, Im CU, Choi SH, Lee SE, Ko SK, Sohn UD. Relaxation effect of synthetic ceramide analogues in cat esophageal smooth muscle cells. Korean J Physiol Pharmacol. 2008;12:137-142.
8. Eto M, Bennouna J, Hunter OC, Hershberger PA, Kanto T, Johnson CS, Lotze MT, Amoscato AA. C16 ceramide accumulates following androgen ablation in LNCaP prostate cancer cells. Prostate. 2003;57:66-79. (Pubitemid 37070151)
9. Selzner M, Bielawska A, Morse MA, Rüdiger HA, Sindram D, Hannun YA, Clavien PA. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 2001;61:1233-1240. (Pubitemid 32174448)
10. Liu X, Elojeimy S, El-Zawahry AM, Holman DH, Bielawska A, Bielawski J, Rubinchik S, Guo GW, Dong JY, Keane T, Hannun YA, Tavassoli M, Norris JS. Modulation of ceramide metabolism enhances viral protein apoptin's cytotoxicity in prostate cancer. Mol Ther. 2006;14:637-646.
11. Senchenkov A, Litvak DA, Cabot MC. Targeting ceramide metabolism - a strategy for overcoming drug resistance. J Natl Cancer Inst. 2001;93:347-357. (Pubitemid 32229379)
12. Dindo D, Dahm F, Szulc Z, Bielawska A, Obeid LM, Hannun YA, Graf R, Clavien PA. Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells. Mol Cancer Ther. 2006;5:1520-1529. (Pubitemid 44070489)
13. Senkal CE, Ponnusamy S, Rossi MJ, Sundararaj K, Szulc Z, Bielawski J, Bielawska A, Meyer M, Cobanoglu B, Koybasi S, Sinha D, Day TA, Obeid LM, Hannun YA, Ogretmen B. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. J Pharmacol Exp Ther. 2006;317:1188-1199. (Pubitemid 43764124)
14. Bedia C, Triola G, Casas J, Llebaria A, Fabriàs G. Analogs of the dihydroceramide desaturase inhibitor GT11 modified at the amide function: synthesis and biological activities. Org Biomol Chem. 2005;3:3707-3712. (Pubitemid 41603768)
15. Granot T, Milhas D, Carpentier S, Dagan A, Ségui B, Gatt S, Levade T. Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs. Leukemia. 2006;20:392-399. (Pubitemid 43291734)
16. Morales A, París R, Villanueva A, Llacuna L, García-Ruiz C, Fernández-Checa JC. Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo. Oncogene. 2007;26:905-916.
17. Nam EJ, Lee HS, Lee YJ, Joo WS, Maeng SH, Im HI, Park CW, Kim YS. Ceramide ia involved in MPP+-induced cytotoxicity in human neuroblastoma cells. Korean J Physiol Pharmacol. 2002;6:281-286. (Pubitemid 36181864)
18. Raisova M, Goltz G, Bektas M, Bielawska A, Riebeling C, Hossini AM, Eberle J, Hannun YA, Orfanos CE, Geilen CC. Bcl-2 overexpression prevents apoptosis induced by ceramidase inhibitors in malignant melanoma and HaCaT keratinocytes. FEBS Lett. 2002;516:47-52. (Pubitemid 34311931)
19. Selzner M, Bielawska A, Morse MA, Rüdiger HA, Sindram D, Hannun YA, Clavien PA. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 2001;61:1233-1240. (Pubitemid 32174448)
20. Alphonse G, Bionda C, Aloy MT, Ardail D, Rousson R, Rodriguez-Lafrasse C. Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels. Oncogene. 2004;23:2703-2715. (Pubitemid 38586324)
21. Lépine S, Lakatos B, Courageot MP, Le Stunff H, Sulpice JC, Giraud F. Sphingosine contributes to glucocorticoid-induced apoptosis of thymocytes independently of the mitochondrial pathway. J Immunol. 2004;173:3783-3790. (Pubitemid 39280740)
22. Bielawska A, Greenberg MS, Perry D, Jayadev S, Shayman JA, McKay C, Hannun YA. (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J Biol Chem. 1996;271:12646-12654. (Pubitemid 26160940)
23. Samsel L, Zaidel G, Drumgoole HM, Jelovac D, Drachenberg C, Rhee JG, Brodie AM, Bielawska A, Smyth MJ. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts. Prostate. 2004;58:382-393. (Pubitemid 38295032)
24. Holman DH, Turner LS, El-Zawahry A, Elojeimy S, Liu X, Bielawski J, Szulc ZM, Norris K, Zeidan YH, Hannun YA, Bielawska A, Norris JS. Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemother Pharmacol. 2008;61:231-242. (Pubitemid 350160321)
25. Usta J, El Bawab S, Roddy P, Szulc ZM, Yusuf, Hannun A, Bielawska A. Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase. Biochemistry. 2001;40:9657-9668. (Pubitemid 32757905)
26. Boyd AE 3rd. Sulfonylurea receptors, ion channels, and fruit flies. Diabetes. 1988;37:847-850.
27. Maren TH. Relatons between structure and biological activity of sulfonamides. Annu Rev Pharmacol Toxicol. 1976;16:309-327.
28. Drews J. Drug discovery: a historical perspective. Science. 2000;287:1960-1964. (Pubitemid 30158662)
29. Abbate F, Casini A, Owa T, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg Med Chem Lett. 2004;14:217-223. (Pubitemid 38010223)
30. Ghorab MM, Noaman E, Ismail MM, Heiba HI, Ammar YA, Sayed MY. Novel antitumor and radioprotective sulfonamides containing pyrrolo (2,3-d]pyrimidines. Arzneimittelforschung. 2006;56:405-413. (Pubitemid 44047519)
31. Rostom SA. Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems. Bioorg Med Chem. 2006;14:6475-6485. (Pubitemid 44233325)
32. Supuran CT, Casini A, Mastrolorenzo A, Scozzafava A. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents. Mini Rev Med Chem. 2004;4:625-632. (Pubitemid 38961227)
33. Kim YJ, Kim EA, Sohn UD, Yim CB, Im C. Cytotoxic activity and structure activity relationship of ceramide analogues in Caki-2 and HL-60 cells. Korean J Physiol Pharmacol. 2010;14:441-447.
34. Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, Gazdar AF. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res. 1987;47:5875-5879. (Pubitemid 18018721)
35. SYBYL Molecular Modeling Software. USA: Tripos Inc., St. Louis; 2010.
36. Chang YT, Choi J, Ding S, Prieschl EE, Baumruker T, Lee JM, Chung SK, Schultz PG. The synthesis and biological characterization of a ceramide library. J Am Chem Soc. 2002;124:1856-1857. (Pubitemid 34215294)